Abstract
Whatever the underlying immunopathologic mechanism, glomerular disease has limited clinical expression, reducible to five basic syndromes. And while the immunopathology remains to be defined more satisfactorily, significant therapeutic gains have been made in treating some forms of glomerulonephritis with steroids, immunosuppressive drugs, and plasma exchange.

This publication has 1 reference indexed in Scilit: